More on CELG

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings
- Holders

Financials

Income Statement
Balance Sheet
Cash Flow Statement

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

CELG Income Statement

Click line-items for a historical chart and %
Revenue:
Net product sales 1.84B
Collaborative agreements and other revenue 2.7M
Royalty revenue 25.4M
Total revenue 1.87B
Expenses:
Cost of goods sold (excluding amortization of acquired intangible assets)
Research and development 456.9M
Selling, general and administrative 491.8M
Amortization of acquired intangible assets
Acquisition related (gains) charges and restructuring, net 900K
Total costs and expenses 1.11B
Operating income 758.9M
Other income and expense:
Interest and investment income, net 7.3M
Equity in (gains) losses of affiliated companies
Interest expense -41.6M
Other income, net -17.8M
Income before income taxes 706.8M
Income tax provision 109M
Net income 597.8M
Less: Net loss attributable to non-controlling interest
Net income attributable to Celgene
Net income per share attributable to Celgene:
Basic 0.75
Diluted 0.72
Weighted average shares:
Basic 799.6M
Diluted 831M